Methotrexat Ebewe

Methotrexate, the active ingredient in Methotrexat Ebewe, is an antimetabolite (folate antagonist) presented as an oral formulation for oral use. It is employed in the management of autoimmune disorders, certain cancers, and ectopic pregnancy. It works by interfering with DNA synthesis, thereby reducing abnormal cell proliferation.

GNH USA supplies Methotrexat Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to facilitate import and distribution across multiple regions.

Methotrexate is used in several disease categories, primarily targeting immune‑mediated conditions and certain malignancies.

- Rheumatoid arthritis: reduces joint inflammation and slows structural damage progression. - Psoriasis: improves skin lesions and decreases plaque formation. - Acute lymphoblastic leukemia: induces remission by inhibiting leukemic cell proliferation. - Non‑Hodgkin lymphoma: contributes to tumor control through cytotoxic effects on malignant lymphocytes. - Ectopic pregnancy: terminates trophoblastic tissue non‑surgically.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea and vomiting - Fatigue or malaise - Mouth sores (stomatitis)

Serious or Rare Side Effects: - Severe liver toxicity (hepatitis, fibrosis) - Pulmonary fibrosis or interstitial pneumonitis - Bone marrow suppression leading to pancytopenia

Methotrexate requires careful monitoring and specific safety measures.

- Liver function monitoring: perform baseline and periodic liver enzyme tests. - Hematologic monitoring: check complete blood counts regularly. - Renal function assessment: adjust dosing if renal impairment is present. - Pregnancy contraindication: avoid use in women who are pregnant or may become pregnant. - Breastfeeding restriction: do not breastfeed during treatment and for a suitable wash‑out period. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Methotrexate may interact with other medicines, altering efficacy or toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate plasma levels and toxicity. - Trimethoprim‑sulfamethoxazole: enhances myelosuppression risk. - Live vaccines: risk of severe infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may affect absorption and increase gastrointestinal side effects. - Phenytoin and other enzyme‑inducing antiepileptics: can reduce methotrexate effectiveness. - Alcohol consumption: heightens risk of liver injury.